Showing results (341-350 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|September 13, 2019
Sarcoma patients' quality of life from diagnosis to yearly follow-up: experience from an Italian tertiary care centerGabriella Maggi, Irene Terrenato, Luca Giacomelli, et al.
Future Oncology (London, England)|September 13, 2019
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreasPhilip A Philip, Marc E Buyse, Angela T Alistar, et al.
Future Oncology (London, England)|September 14, 2019
Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trialsJorge E Cortes, Hervé Dombret, Akil Merchant, et al.
Future Oncology (London, England)|August 3, 2019
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag studyMaximilian J Hochmair, Alessandro Morabito, Desiree Hao, et al.
Future Oncology (London, England)|May 13, 2015
Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?Jianbo Li, Guojian Zhang, Xuemei Wang, et al.
Future Oncology (London, England)|May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphomaPatrick M Reagan, Jonathan W Friedberg
Future Oncology (London, England)|May 13, 2015
The skewed balance between Tregs and Th17 in chronic lymphocytic leukemiaMehdi Yousefi, Ali Akbar Movassaghpour, Karim Shamsasenjan, et al.
Future Oncology (London, England)|May 9, 2015
Personalization of loco-regional care for primary breast cancer patients (part 2)Masakazu Toi, Eric P Winer, John R Benson, et al.
Future Oncology (London, England)|May 9, 2015
A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomasPierre Feugier
Future Oncology (London, England)|May 9, 2015
Human papillomavirus confers radiosensitivity in cancer cervix: a hypothesis toward a possible restoration of apoptotic pathways based on clinical outcomesNiloy Ranjan Datta, Shalini Singh, Piyush Kumar, et al.
Pageof 451